Lucky Supersoft
NDC Package 47046-176-01
Package Information
Lucky Supersoft is ■ for itching of skin irritation, inflammation and rashes: ■ adults and children 2 years of age and older: apply to affected area not more than 3 to 4 times daily ■ children under 2 years of age: ask a doctor for external anal and genital itching, adults: ■ when practical, clean the affected area with mild soap and water and rinse thoroughly ■ gently dry by patting or blotting with toilet tissue or a soft cloth before applying ■ apply to affected area not more than 3 to 4 times daily ■ children under 12 years of age: ask a doctor. Marketed by Anicare Pharmaceuticals Pvt. Ltd., this product is identified by NDC 47046-176 and is authorized under FDA application part348.
Identification & Billing
- RxCUI: 106258 - hydrocortisone 1 % Topical Cream
- RxCUI: 106258 - hydrocortisone 10 MG/ML Topical Cream
- RxCUI: 106258 - hydrocortisone 1 % (as hydrocortisone acetate 1.2 % ) Topical Cream
- RxCUI: 106258 - hydrocortisone 1 GM per 100 GM Topical Cream
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 47046 - Anicare Pharmaceuticals Pvt. Ltd.
- 47046-176 - Lucky Supersoft
- 47046-176-01 - 14 g in 1 TUBE
- 47046-176 - Lucky Supersoft
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 47046-176-01 identifies a specific commercial package of 14 g in 1 tube of Lucky Supersoft Maximum Strength, labeled by Anicare Pharmaceuticals Pvt. Ltd.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Anicare Pharmaceuticals Pvt. Ltd. on January 31, 2015. The current certification is valid through December 31, 2021.
How is this Anicare Pharmaceuticals Pvt. Ltd. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 47046017601. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.